Paris-based SMS verification technology company Prelude has secured $8 million in seed funding led by Singular and Seedcamp. The company, founded in 2022 by Matias Berny and Quentin Le Bras, develops ...

WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD), a precision oncology company, has shared its third-quarter ...

Prelude is a relatively new French startup that focuses on SMS verification; it's announcing new funding from Singular and ...

Analyst Reni Benjamin from JMP Securities reiterated a Buy rating on Prelude Therapeutics (PRLD – Research Report) and keeping the price ...

Presented interim data from the ongoing Phase 1 dose escalation study of PRT3789, its first-in-class IV SMARCA2 degrader, ...

In a report released today, Peter Lawson from Barclays maintained a Sell rating on Prelude Therapeutics (PRLD – Research Report), with a price target of $1.00. The company’s shares closed yesterday at ...

Prelude Therapeutics Inc (NASDAQ:PRLD), a clinical-stage biopharmaceutical company focused on developing precision oncology therapies, finds itself at a critical juncture as it approaches several ...

UK supermajor Shell is again facing the threat of workers downing tools on its Prelude floating liquefied natural gas (FLNG) facility deployed on the field of the same name offshore Australia.

Spread the loveIn a move that has excited automotive enthusiasts worldwide, Honda has announced the revival of its iconic Prelude nameplate for the 2026 model year. This new iteration aims to blend ...

If the Prelude previews the future ... According to recent reports, the company is working on simulated shifts and soundtracks that call to mind classic cars like the NSX, although it hasn ...

Interim data from ongoing trial of PRT3789 showed additional clinical activity at higher doses in patients with non-small ...